Page last updated: 2024-10-29

staurosporine aglycone and Leukemia P388

staurosporine aglycone has been researched along with Leukemia P388 in 2 studies

staurosporine aglycone: metabolite from culture broth of Nocardiopsis sp.; a neurotrophin antag; inhibits BDNF TrkB receptor

Leukemia P388: An experimental lymphocytic leukemia originally induced in DBA/2 mice by painting with methylcholanthrene.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Pereira, ER1
Belin, L1
Sancelme, M1
Prudhomme, M1
Ollier, M1
Rapp, M1
Sevère, D1
Riou, JF1
Fabbro, D1
Meyer, T1
Horton, PA1
Longley, RE1
McConnell, OJ1
Ballas, LM1

Other Studies

2 other studies available for staurosporine aglycone and Leukemia P388

ArticleYear
Structure-activity relationships in a series of substituted indolocarbazoles: topoisomerase I and protein kinase C inhibition and antitumoral and antimicrobial properties.
    Journal of medicinal chemistry, 1996, Oct-25, Volume: 39, Issue:22

    Topics: Animals; Anti-Bacterial Agents; Antineoplastic Agents; Bacillus cereus; Carbazoles; Escherichia coli

1996
Staurosporine aglycone (K252-c) and arcyriaflavin A from the marine ascidian, Eudistoma sp.
    Experientia, 1994, Sep-15, Volume: 50, Issue:9

    Topics: Africa, Western; Animals; Antineoplastic Agents; Carbazoles; Cell Adhesion; Cell Division; Humans; I

1994